Periurethral bulking agents for female stress urinary incontinence in Canada. - Wikidata - wikimedia - TriplyDB

Periurethral bulking agents for female stress urinary incontinence in Canada.

Periurethral bulking agents for female stress urinary incontinence in Canada.

http://www.wikidata.org/entity/Q33769908

about

Stress urinary incontinence treatment: Focus should be on identifying best candidates for surgical success in the first place.The Novel and Minimally Invasive Treatment Modalities for Female Pelvic Floor Muscle Dysfunction; Beyond the Traditional

P2860

Q41240452-C317C573-3E5E-45B1-96CC-17522D53658A Q57152664-3C3AF29A-ED07-4BFB-9FB1-98EEE4768E49

P2860

Periurethral bulking agents for female stress urinary incontinence in Canada.

http://www.wikidata.org/entity/Q33769908

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Periurethral bulking agents for female stress urinary incontinence in Canada.

@ast

Periurethral bulking agents for female stress urinary incontinence in Canada.

@en

type

label

Periurethral bulking agents for female stress urinary incontinence in Canada.

@ast

Periurethral bulking agents for female stress urinary incontinence in Canada.

@en

prefLabel

Periurethral bulking agents for female stress urinary incontinence in Canada.

@ast

Periurethral bulking agents for female stress urinary incontinence in Canada.

@en

P1433

Q33769908-DCFC8008-C7C4-4F7B-82B4-CEA151BB2DAE

P1476

Q33769908-346FE632-EE5B-4912-BAFE-79CFA73A9796

P2093

Q33769908-418A4BAA-080A-4D02-837B-0DB0B93BAF17

Q33769908-8C50BC6F-EB7E-4C84-AD3C-81817F112D75

P2860

Q33769908-0B3F5091-7F87-4D44-8DBF-FCB523DA3E85

Q33769908-0C086CED-B138-4A7B-9DA3-92BB317CEB15

Q33769908-14721977-A31F-4203-BADF-B363F808B36E

Q33769908-16BD5C49-11BB-4773-AA5F-AFA20B8F6744

Q33769908-3AEA25A1-2610-4456-8FB6-EA5139455A4D

Q33769908-8ABAE4ED-4FD8-47BF-ACE3-D33ADE9C18F7

Q33769908-9F1431A1-9C3E-4B32-8BE2-E26DB76D3BF2

Q33769908-B9E7CC69-74DB-4AA1-8B66-460747D6409B

Q33769908-C5FD61A2-9D40-495B-889B-EC1DE0EA1E96

Q33769908-CC443EEE-8387-4843-A474-A18DD2BAD24A

P304

Q33769908-EBEA6076-AD52-4C73-891A-D0FA338450A0

P31

Q33769908-137E12CC-D042-4B1B-B787-8990499DA434

P356

Q33769908-F440A1A2-FFFC-4F6F-A389-B4835768F9CB

P433

Q33769908-98C2AA14-6FAA-4B58-9C78-D60EC98FA508

P478

Q33769908-803DF0A7-348F-4C70-8E9E-D1C0E0447838

P577

Q33769908-87994256-40D3-4F3A-82D0-1B840EA28E64

P698

Q33769908-3E576458-3CF2-48AE-A384-0499685F8569

P932

Q33769908-12572C4D-F3C3-4A20-952F-F0D15EC7C079

P356

P1433

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

P1476

Periurethral bulking agents for female stress urinary incontinence in Canada.

@en

P2093

Adiel Mamut

http://www.w3.org/2001/XMLSchema#string

Kevin V Carlson

http://www.w3.org/2001/XMLSchema#string

P2860

Urethral injection therapy for urinary incontinence in women

The efficacy and safety of urethral injection therapy for urinary incontinence in women: a systematic review

Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress-predominant mixed incontinence.

2012 update: guidelines for adult urinary incontinence collaborative consensus document for the canadian urological association

Urethral bulking agents: techniques and outcomes.

Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically.

Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study.

Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study.

Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence.

Current use of injectable agents for female stress urinary incontinence.

P304

S152-S154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5489/CUAJ.4612

http://www.w3.org/2001/XMLSchema#string

P433

6Suppl2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28616117

http://www.w3.org/2001/XMLSchema#string

P932

5461150

http://www.w3.org/2001/XMLSchema#string